Solasia Pharma KK
TSE:4597
Solasia Pharma KK
Additional Paid In Capital
Solasia Pharma KK
Additional Paid In Capital Peer Comparison
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Solasia Pharma KK
TSE:4597
|
Additional Paid In Capital
¥1.8B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Additional Paid In Capital
¥7.4B
|
CAGR 3-Years
27%
|
CAGR 5-Years
17%
|
CAGR 10-Years
4%
|
|
PeptiDream Inc
TSE:4587
|
Additional Paid In Capital
¥4.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Additional Paid In Capital
¥32.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Additional Paid In Capital
¥2.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-7%
|
S
|
StemRIM Inc
TSE:4599
|
Additional Paid In Capital
¥9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
See Also
What is Solasia Pharma KK's Additional Paid In Capital?
Additional Paid In Capital
1.8B
JPY
Based on the financial report for Mar 31, 2024, Solasia Pharma KK's Additional Paid In Capital amounts to 1.8B JPY.
What is Solasia Pharma KK's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
-25%
Over the last year, the Additional Paid In Capital growth was 18%. The average annual Additional Paid In Capital growth rates for Solasia Pharma KK have been -31% over the past three years , -25% over the past five years .